CONTENTSOFSUPPLEMENT9 - EDQM
EUROPEAN PHARMACOPOEIA 9.4 Contents of Supplement 9.4 The following text is deleted as of1 July 2017. GENERAL CHAPTERS 2.6.19. Test for neurovirulence of poliomyelitis vaccine (oral) The following text is deleted as of1 April 2017. GENERAL CHAPTERS
Download CONTENTSOFSUPPLEMENT9 - EDQM
Information
Domain:
Source:
Link to this page:
Documents from same domain
Comments concerning revised texts published in …
www.edqm.eu© Pharmeuropa | Useful information | June 2017 1 Comments concerning revised texts published in Supplement 9.3 The following information details the technical modifications that have been made to revised
OMCL Network of the Council of Europe QUALITY …
www.edqm.euomcl network of the council of europe quality management document pa/ph/omcl (12) 77 7r qualification of equipment annex 8: qualification of balances
General European OMCL Network (GEON) QUALITY …
www.edqm.euPA/PH/OMCL (11) 04 R6 – Annex 1 to Qualification of Equipment: Qualification of LC Equipment p. 3/23 TABLE I Level III. Periodic and motivated instrument checks
OMCL Network of the Council of Europe GENERAL …
www.edqm.euPA/PH/OMCL (13) 82 2R 2/9 VALIDATION OF ANALYTICAL PROCEDURES GUIDELINE FOR OMCLs INTRODUCTION The two ICH Guidelines on “Validation of Analytical Procedures: “Definition/ Terminology
The structure of the Ph. Eur. - European Directorate …
www.edqm.euGeneral Notices General Notices Put at the very beginning of the Ph. Eur. (page 1), they address general issues and are aimed at providing the basic information to the user.
GGuideuide - EDQM
www.edqm.euGGuideuide for the elaboration of monographs on herbal drugs and herbal drug preparations European Pharmacopoeia European Directorate for the Quality of Medicines & HealthCare
Technical guide for the elaboration of …
www.edqm.euII.5.7. Absorption spectrophotometry (ultraviolet and visible) (2.2.25.) ..... 22 II.5.8.
GOODPRACTICE GUIDELINES - European …
www.edqm.eu1 GOODPRACTICE GUIDELINES ForImplementingStand ardsandSpecificationsf ortheQualitySysteminBlo od Establishments IntroductoryNote Good Practice Guidelines have been prepared through an adhoc co-operation between the European
EUROPEAN PHARMACOPOEIA 9.1 …
www.edqm.euEUROPEAN PHARMACOPOEIA 9.1 Contents of Supplement 9.1 CONTENTSOFSUPPLEMENT9.1 A vertical line in the margin indicates where part of a text has been revised or corrected. A horizontal line in the margin indicates
Style Guide of the European Pharmacopoeia - EDQM
www.edqm.euEuropean Pharmacopoeia 2017 Pharmacopée Européenne Style Guide of the European Pharmacopoeia Guide de rédaction de la Pharmacopée Européenne
Related documents
Annex 2 - WHO
www.who.intAnnex 2 51 Introduction WHO Requirements for oral poliomyelitis vaccine (OPV) were first formulated in 1962 (1), and revised in 1965 (2), and then again in 1971 (3), when an appendix describing the production of OPV in human diploid cells was added.
Transgenic mice as an alternative to monkeys for ...
www.who.intTransgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study
EUROPEAN PHARMACOPOEIA 9.5 CONTENTSOFSUPPLEMENT9 - EDQM
www.edqm.euEUROPEAN PHARMACOPOEIA 9.5 Contents of Supplement 9.5 CONTENTSOFSUPPLEMENT9.5 A vertical line in the margin indicates where part of a text has been revised or corrected. A horizontal line in the margin indicates